CLIMB BIO, INC. Operating Leases, Rent Expense
CLIMB BIO, INC. (CLYM) reported Operating Leases, Rent Expense of $100.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2024-05-15
- CLIMB BIO, INC. operating leases, rent expense for the quarter ending 2024-03-31 was $100.00K, a 0.00% change year-over-year.
- CLIMB BIO, INC. operating leases, rent expense for the quarter ending 2023-12-31 was $200.00K, a 100.00% increase year-over-year.
- CLIMB BIO, INC. operating leases, rent expense for the quarter ending 2023-09-30 was $100.00K, a 0.00% change year-over-year.
- CLIMB BIO, INC. operating leases, rent expense for the quarter ending 2023-06-30 was $100.00K, a 0.00% change year-over-year.
- CLIMB BIO, INC. operating leases, rent expense for fiscal 2023 was $400.00K, a 20.00% decline from fiscal 2022.
- CLIMB BIO, INC. operating leases, rent expense for fiscal 2022 was $500.00K, a 249900.00% increase from fiscal 2021.
- CLIMB BIO, INC. operating leases, rent expense for fiscal 2021 was $200.00, a 99.61% decline from fiscal 2020.
- CLIMB BIO, INC. operating leases, rent expense for fiscal 2020 was $51.00K.
| Period end | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2024-03-31 | $100.00K 10-Q · filed 2024-05-15 | $300.00K derived: sum of 2 quarters · filed 2024-05-15 | $400.00K derived: sum of 3 quarters · filed 2024-05-15 | $500.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $300.00K derived: sum of 2 quarters · filed 2024-03-28 | $400.00K derived: sum of 3 quarters · filed 2024-03-28 | $400.00K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-14 | $200.00K derived: sum of 2 quarters · filed 2023-11-14 | $200.00K 10-Q · filed 2023-11-14 | $400.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2023-06-30 | $100.00K 10-Q · filed 2023-08-10 | $200.00K 10-Q · filed 2023-08-10 | $300.00K derived: sum of 3 quarters · filed 2024-05-15 | $400.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-15 | $200.00K derived: sum of 2 quarters · filed 2024-05-15 | $300.00K derived: sum of 3 quarters · filed 2024-05-15 | $400.00K derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $200.00K derived: sum of 2 quarters · filed 2024-03-28 | $300.00K derived: sum of 3 quarters · filed 2024-03-28 | $500.00K 10-K · filed 2024-03-28 | $500.00 10-K · filed 2023-03-06 |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-14 | $200.00K derived: sum of 2 quarters · filed 2023-11-14 | $400.00K 10-Q · filed 2023-11-14 | $200.20K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-10 | $200.00K 10-Q · filed 2023-08-10 | $100.20K derived: sum of 3 quarters · filed 2023-08-10 | $200.20K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-11 | $200.00 derived: sum of 2 quarters · filed 2023-05-11 | $100.20K derived: sum of 3 quarters · filed 2023-05-11 | $114.20K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$99.80K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $200.00 derived: sum of 2 quarters · filed 2023-03-06 | $14.20K derived: sum of 3 quarters · filed 2023-03-06 | $200.00 10-K · filed 2023-03-06 | $248.00K 10-K · filed 2022-03-07 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $114.00K derived: sum of 2 quarters · filed 2022-11-14 | $100.00K 10-Q · filed 2022-11-14 | $141.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $14.00K 10-Q · filed 2022-08-15 | $28.00K 10-Q · filed 2022-08-15 | $41.00K derived: sum of 3 quarters · filed 2022-08-15 | $54.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-16 | $27.00K derived: sum of 2 quarters · filed 2022-05-16 | $40.00K derived: sum of 3 quarters · filed 2022-05-16 | $52.00K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $26.00K derived: sum of 2 quarters · filed 2022-03-07 | $38.00K derived: sum of 3 quarters · filed 2022-03-07 | $51.00K 10-K · filed 2022-03-07 | |
| 2020-09-30 | $13.00K 10-Q · filed 2021-11-08 | $25.00K derived: sum of 2 quarters · filed 2021-11-08 | $38.00K 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | $12.00K 10-Q · filed 2021-09-13 | $25.00K 10-Q · filed 2021-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |